Pulse Biosciences, Inc. PLSE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -80.06M | -74.57M | -72.78M | -74.73M | -68.03M |
| Total Depreciation and Amortization | 1.02M | 1.04M | 1.07M | 1.10M | 1.14M |
| Total Amortization of Deferred Charges | 281.00K | 281.00K | -- | -- | -- |
| Total Other Non-Cash Items | 19.32M | 19.49M | 23.17M | 24.77M | 22.13M |
| Change in Net Operating Assets | -1.67M | -1.45M | -5.58M | 358.00K | 265.00K |
| Cash from Operations | -61.10M | -55.20M | -54.12M | -48.51M | -44.50M |
| Capital Expenditure | -290.00K | -303.00K | -315.00K | -263.00K | -239.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -20.00K | -20.00K | -20.00K | -20.00K |
| Cash from Investing | -290.00K | -323.00K | -335.00K | -283.00K | -259.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 56.66M | 4.62M | 17.15M | 65.03M | 124.91M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -57.00K | -- | -59.00K | -3.00K |
| Cash from Financing | 56.66M | 4.56M | 17.15M | 64.98M | 124.91M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.73M | -50.96M | -37.30M | 16.18M | 80.15M |